EichorEICHOR
Location: Garden Grove Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Garden Grove

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
NA · Alliance for Clinical Trials in Oncology · NCT07091617Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · NRG Oncology · NCT05174169Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc
Phase 3 · Alliance for Clinical Trials in Oncology · NCT06632327ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Alliance for Clinical Trials in Oncology · NCT06876714Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · National Cancer Institute (NCI) · NCT04269902Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Phase N/A · Alliance for Clinical Trials in Oncology · NCT04242095Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipol
Phase 2 · Collaborative Neuroscience Research - Garden Grove /ID# 2734 · AbbVie · NCT07220460Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
NA · Eastern Cooperative Oncology Group · NCT05108298Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Phase 3 · ECOG-ACRIN Cancer Research Group · NCT04566328mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Neg
Phase 3 · Alliance for Clinical Trials in Oncology · NCT05677490A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V60
Phase 2 · SWOG Cancer Research Network · NCT04511013Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
NA · NRG Oncology · NCT05080673Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
Phase 2 · SWOG Cancer Research Network · NCT04205968Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Phase 3 · ECOG-ACRIN Cancer Research Group · NCT04423211Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head
Phase 2 · ECOG-ACRIN Cancer Research Group · NCT02734537A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
Phase 3 · CenExel CNS - Garden Grove (Collaborative Neuroscience Resea · Otsuka Pharmaceutical Development & Commercialization, Inc. · NCT06894212S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac
Phase 3 · SWOG Cancer Research Network · NCT03418961Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors
Phase N/A · ECOG-ACRIN Cancer Research Group · NCT06002828Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
NA · Alliance for Clinical Trials in Oncology · NCT07283939S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic
NA · SWOG Cancer Research Network · NCT03723928Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Phase 3 · ECOG-ACRIN Cancer Research Group · NCT06475989Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabo
Phase 2 · National Cancer Institute (NCI) · NCT03866382Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung
Phase 3 · National Cancer Institute (NCI) · NCT04267848Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Phase 3 · ECOG-ACRIN Cancer Research Group · NCT03937635A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I
Phase 2 · Collaborative Neuroscience Research - Garden Grove /ID# 2719 · AbbVie · NCT06696755A Study to Evaluate the Effect of KarXT on Urological Safety
Phase 4 · CenExel CNS - Garden Grove · Bristol-Myers Squibb · NCT07221877Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Phase 3 · NRG Oncology · NCT06580314Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Phase 3 · National Cancer Institute (NCI) · NCT04181060MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase N/A · Stryker Instruments · NCT03072927Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colore
Phase 3 · SWOG Cancer Research Network · NCT07018869
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.